articleThe Journal of Experimental MedicineMay 16, 2011BRONZE OA

IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease

John Radcliffe Hospital · University of Oxford

PubMed
Indexed incrossrefpubmed

Abstract

Results of experimental and genetic studies have highlighted the role of the IL-23/IL-17 axis in the pathogenesis of inflammatory bowel disease (IBD). IL-23-driven inflammation has been primarily linked to Th17 cells; however, we have recently identified a novel population of innate lymphoid cells (ILCs) in mice that produces IL-17, IL-22, and IFN-γ in response to IL-23 and mediates innate colitis. The relevance of ILC populations in human health and disease is currently poorly understood. In this study, we have analyzed the role of IL-23-responsive ILCs in the human intestine in control and IBD patients. Our results show increased expression of the Th17-associated cytokine genes IL17A and IL17F among…

Citation impact

624
total citations
FWCI
18.56
Percentile
100%
References
32
Citations per year

Authors

8

Topics & keywords

Keywords
  • Innate lymphoid cell
  • Immunology
  • Interleukin 22
  • Inflammation
  • Inflammatory bowel disease
  • Interleukin 23
  • Population
  • Interleukin-7 receptor
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding